Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

Abstract Background Treatment guidelines suggest either a low-dose or high-dose approach when prescribing amikacin for nontuberculous mycobacterial pulmonary disease (NTM PD), but data supporting the low-dose approach are limited. The purpose of this study was to describe the safety and efficacy of...

Full description

Bibliographic Details
Published in:BMC Pharmacology and Toxicology
Main Authors: Maria Luisa Aznar, Theodore K. Marras, Ahmed Said Elshal, Mahtab Mehrabi, Sarah K. Brode
Format: Article
Language:English
Published: BMC 2019-06-01
Subjects:
Amikacin
NTM lung disease
Nontuberculous mycobacteria
Online Access:http://link.springer.com/article/10.1186/s40360-019-0302-1

Internet

http://link.springer.com/article/10.1186/s40360-019-0302-1

Similar Items